newsfilter
← Latest News
GlobeNewswire·

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs